Irene Bargagna

PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients

Marzia Del Re, Stefania Crucitta, Claudia De Angelis et al. · Pharmacological Research · 2020 · 38 citations

Medicine, Cancer Biology, Oncology +17

Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib

Marzia Del Re, Stefania Crucitta, Claudia Omarini et al. · The Breast · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +10

CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients

Stefania Crucitta, Martina Ruglioni, Irene Bargagna et al. · Cancers · 2023 · 21 citations · Full text

Medicine, Endocrinology, Oncology +16